Keywords: locaserin, trial, passes, 1-year, safety, review, usa

Locaserin trial passes 1-year safety review

Article | 31 March 2008

Print This

The USA's Arena Pharmaceuticals is continuing a pivotal Phase III trial of its obesity drug locaserin HCl, after a go ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in